NCT02119897View on ClinicalTrials.gov

Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

April 30, 2016

Conditions
Oropharyngeal MucositisMyeloablative Hematopoietic Cell TransplantationLow Level Light Therapy
Interventions
DEVICE

Low Level Light Therapy

Trial Locations (2)

02115

Boston Children's Hospital, Boston

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT02119897 - Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients | Biotech Hunter | Biotech Hunter